CLINICAL_TRIALS
trial_result
· 2024-07-05
Clinical Trial Update: HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism [Phase 3]
Summary
A Phase 3 study named HEXT assessed the effects of parathyroid hormone on skeletal health in hypoparathyroidism; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Hypoparathyroidism | Phase 3 | Status: COMPLETED | Results posted: 2024-07-05